COVID-19's Radiologic, Functional, and Serologic Consequences at 6-Month and 18-Month Follow-up: A Prospective Cohort Study

• Published in: Journal of Korean medical science 2024, 39(32), , pp.1-15
• Main Authors: Kim, Cherry, Seok, Hyeri, Kim, Jooyun, Park, Dae Won, van Assen, Marly, De Cecco, Carlo N, Choi, Hangseok, Kim, Chohee, Hwang, Sung Ho, Yong, Hwan Seok, Oh, Yu-Whan, Choi, Won Suk
• Format: Article
• Language: English
• Subjects: Adult; Aged; Antibodies, Viral - blood; COVID-19 - diagnostic imaging; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Immunoglobulin G - blood; Lung - diagnostic imaging; Lung - pathology; Male; Middle Aged; Original; Prospective Studies; Respiratory Function Tests; Risk Factors; SARS-CoV-2 - immunology; SARS-CoV-2 - isolation & purification; Tomography, X-Ray Computed; Vital Capacity; 의학일반
• ISSN: 1011-8934; 1598-6357; 1598-6357
• DOI: 10.3346/jkms.2024.39.e228

We evaluated the radiologic, pulmonary functional, and antibody statuses of coronavirus disease 2019 (COVID-19) patients 6 and 18 months after discharge, comparing changes in status and focusing on risk factors for residual computed tomography (CT) abnormalities. This prospective cohort study was conducted on COVID-19 patients discharged between April 2020 and January 2021. Chest CT, pulmonary function testing (PFT), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) measurements were performed 6 and 18 months after discharge. We evaluated factors associated with residual CT abnormalities and the correlation between lesion volume in CT (lesion ), PFT, and IgG levels. This study included 68 and 42 participants evaluated 6 and 18 months, respectively, after hospitalizations for COVID-19. CT abnormalities were noted in 22 participants (32.4%) at 6 months and 13 participants (31.0%) at 18 months. Lesion was significantly lower at 18 months than 6 months ( < 0.001). Patients with CT abnormalities at 6 months showed lower forced expiratory volume in 1 second (FEV1) and FEV1/forced vital capacity (FVC), and patients with CT abnormalities at 18 months exhibited lower FVC. FVC significantly improved between 6 and 18 months of follow-up (all < 0.0001). SARS-CoV-2 IgG levels were significantly higher in patients with CT abnormalities at 6 and 18 months ( < 0.001). At 18-month follow-up assessments, age was associated with CT abnormalities (odds ratio, 1.17; 95% confidence interval, 1.03-1.32; = 0.01), and lesion showed a positive correlation with IgG level ( = 0.643, < 0.001). At 18-month follow-up assessments, 31.0% of participants exhibited residual CT abnormalities. Age and higher SARS-CoV-2 IgG levels were significant predictors, and FVC was related to abnormal CT findings at 18 months. Lesion and FVC improved between 6 and 18 months. Clinical Research Information Service Identifier: KCT0008573.